Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aurora Cannabis Inc. (ACB.TO)
CAD3.77
+0.01 (+0.27%)
CA TSX Healthcare Drug Manufacturers - Specialty & Generic
Address
500 - 10355 Jasper Avenue T5J 1Y6
Edmonton, AB, CA
Edmonton, AB, CA
CEO
Miguel Martin
Website
auroramj.com
IPO
2016-10-05
ISIN CA05156X8504
Also trades on
Frankfurt Stock Exchange · 21P.F (EUR)
Frankfurt Stock Exchange · 21P1.F (EUR)
NASDAQ Global Select · ACB (USD)
Toronto Stock Exchange · ACB.TO (CAD)
Description
Aurora Cannabis Inc. is a Canada-based firm specializing in the cultivation, processing, and global distribution of cannabis and its various derivative products. The company's operations encompass a broad spectrum of the cannabis industry, from facility engineering and design to genetic research, production, and the development of new products, all supported by extensive wholesale and retail networks. For medical users, Aurora offers diverse strains of dried cannabis, oils, capsules, and topical kits. Additionally, it markets a range of accessories, including vaporizers, consumable parts, herb mills (specifically for CanniMed products), grinders, and lockable vaporizer containers. The company is committed to advancing medical cannabis, with ongoing development across oral, topical, edible, and inhalable product categories. Aurora also provides key services such as patient counseling, design and construction assistance, and comprehensive analytical product testing for cannabis, alongside operating CanvasRX, a network dedicated to cannabis counseling and outreach. Its expansive brand family includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The corporate headquarters are located in Edmonton, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD3.77
+0.01 (+0.27%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
435.5K
Beta
1.35
Float Shares
56.40M
Free Float %
99.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.70% | -13.27% | -7.41% | -11.27% | -42.88% | -26.34% | -48.67% | -43.33% | -96.37% | -98.01% | -98.01% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Hold
Price Targets & DCF
Current price
3.77
Ratings Trend (MoM)
60% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-12.23
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-6.6% Q1'26: -58.0% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-7,643.9% Q1'26: -125.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-59.3% Q1'26: -14.2% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-50.8% Q1'26: -66.1% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-43.9% Q1'26: -27.1% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+1.7% Q1'26: +3.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-0.15× Q1'26: -0.24× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 4 EPS Ana. |
Mar 2027 5 Rev. Ana. 5 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
55.20M
est: 19.93M (+176.9%)
|
245.54M
est: 62.00M (+296.0%)
|
268.70M
est: 258.97M (+3.8%)
|
245.25M
est: 278.94M (-12.1%)
|
221.34M
est: 245.25M (-9.8%)
|
233.29M
est: 175.00M (+33.3%)
|
270.28M
est: 278.98M (-3.1%)
|
343.29M
est: 342.10M (+0.3%)
|
358.35M
351.14M – 365.55M
+4.7% YoY
|
326.25M
291.21M – 347.05M
-9.0% YoY
|
360.32M
351.64M – 369.01M
+10.4% YoY
|
351.40M
313.66M – 373.80M
-2.5% YoY
|
377.80M
337.23M – 401.88M
+7.5% YoY
|
| EBITDA |
101.35M
est: -11.16M (+1,008.1%)
|
-202.99M
est: -34.71M (-484.7%)
|
-3.15B
est: -144.99M (-2,071.8%)
|
-535.29M
est: -156.18M (-242.7%)
|
-1.55B
est: -137.31M (-1,032.2%)
|
-210.74M
est: -97.98M (-115.1%)
|
-12.34M
est: -156.20M (+92.1%)
|
51.35M
est: -191.54M (+126.8%)
|
-200.63M
-204.67M – -196.60M
-4.7% YoY
|
-182.67M
-194.31M – -163.05M
+9.0% YoY
|
-201.74M
-206.60M – -196.88M
-10.4% YoY
|
-196.75M
-209.29M – -175.62M
+2.5% YoY
|
-211.53M
-225.01M – -188.81M
-7.5% YoY
|
| EBIT |
89.09M
est: -12.30M (+824.5%)
|
-291.24M
est: -38.24M (-661.5%)
|
-3.26B
est: -159.74M (-1,943.1%)
|
-633.36M
est: -172.06M (-268.1%)
|
-1.65B
est: -151.28M (-989.6%)
|
-254.32M
est: -107.94M (-135.6%)
|
-45.41M
est: -172.08M (+73.6%)
|
28.80M
est: -211.02M (+113.6%)
|
-221.04M
-225.48M – -216.59M
-4.7% YoY
|
-201.24M
-214.07M – -179.63M
+9.0% YoY
|
-222.25M
-227.61M – -216.90M
-10.4% YoY
|
-216.75M
-230.57M – -193.47M
+2.5% YoY
|
-233.04M
-247.89M – -208.01M
-7.5% YoY
|
| Net Income |
71.94M
est: -220.52M (+132.6%)
|
-293.51M
est: -631.84M (+53.5%)
|
-3.28B
est: -2.38B (-38.0%)
|
-693.63M
est: -12.48B (+94.4%)
|
-1.72B
est: -2.29B (+24.9%)
|
-265.33M
est: -343.68M (+22.8%)
|
-69.33M
est: -34.71M (-99.7%)
|
1.59M
est: 31.24M (-94.9%)
|
-66.62M
-72.04M – -61.20M
-313.2% YoY
|
-13.97M
-655.78M – 638.06M
+79.0% YoY
|
-12.70M
-27.30M – 64.52M
+9.1% YoY
|
4.46M
3.84M – 4.83M
+135.1% YoY
|
20.63M
17.75M – 22.34M
+362.5% YoY
|
| SGA |
109.86M
est: 13.95M (+687.3%)
|
365.38M
est: 43.40M (+741.9%)
|
345.75M
est: 181.27M (+90.7%)
|
194.88M
est: 195.25M (-0.2%)
|
188.99M
est: 171.67M (+10.1%)
|
183.40M
est: 122.49M (+49.7%)
|
156.88M
est: 195.29M (-19.7%)
|
166.47M
est: 239.47M (-30.5%)
|
250.84M
245.79M – 255.88M
+4.7% YoY
|
228.37M
203.85M – 242.93M
-9.0% YoY
|
252.22M
246.14M – 258.30M
+10.4% YoY
|
245.98M
219.56M – 261.65M
-2.5% YoY
|
264.46M
236.05M – 281.31M
+7.5% YoY
|
| EPS |
18.77
est: -3.96 (+574.6%)
|
-36.65
est: -11.33 (-223.4%)
|
-333.92
est: -42.65 (-682.8%)
|
-40.92
est: -223.91 (+81.7%)
|
-79.92
est: -41.00 (-94.9%)
|
-8.17
est: -6.18 (-32.2%)
|
-1.28
est: -0.64 (-99.7%)
|
0.03
est: 0.58 (-95.0%)
|
-1.20
-1.29 – -1.10
-307.6% YoY
|
0.19
-11.76 – 11.44
+115.9% YoY
|
0.31
-0.49 – 1.16
+60.4% YoY
|
0.08
0.07 – 0.09
-73.9% YoY
|
0.37
0.32 – 0.40
+362.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-10 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-09 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
64.20M
OE per share TTM
1.14
Owner's Yield
26.28%
Maintenance CapEx ratio
290.54%
Maint CapEx / Avg PPE
188.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 4 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares S&P/TSX SmallCap Index ETF XCS.TO | 0.07% | 127.6K | 0.60% |
| 2 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 144.9K | 0.40% |
| 3 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 43.5K | 0.22% |
| 4 | State Street SPDR Portfolio Developed World ex-US ETF SPDW | 0.00% | 25.4K | 0.03% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-151.7K
Shares Outstanding
56.71M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Miguel Martin | Chief Executive Officer & Executive Chairman | 3M | male |
| Simona King | Chief Financial Officer | 1M | female |
| Alex Miller | Executive Vice President of Operations & Supply Chain | 859.6K | male |
| Nathalie Clark | Executive Vice President, General Counsel & Corporate Secretary | 816.7K | female |
| Lori Schick | Executive Vice President of Human Resources | 809.9K | female |
| Andre Jerome | Executive Vice President of Global Business Development | 698.7K | male |
| Rick Savone | Senior Vice President of Global Government Relations | — | male |
| David Aird | Executive Vice President of Information Technology | — | male |
| Michelle Lefler | Vice President of Communications & Public Relations | — | female |
| Kerry Miller | Managing Director for Australia & New Zealand | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ACB.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
